LoginSignup
Amneal logo

Amneal

Stock
Stock
ISIN: US03168L1052
Ticker: AMRX
US03168L1052
AMRX

Price

Price

Frequently asked questions

What is Amneal's market capitalization?

The market capitalization of Amneal is $2.58B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Amneal?

Amneal's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.684. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Amneal's stock?

Currently, 4 analysts cover Amneal's stock, with a consensus target price of $8.25. Analyst ratings provide insights into the stock's expected performance.

What is Amneal's revenue over the trailing twelve months?

Over the trailing twelve months, Amneal reported a revenue of $2.68B.

What is the EBITDA for Amneal?

Amneal's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $545.27M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Amneal?

Amneal has a free cash flow of $229.23M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Amneal's stock?

The 5-year beta for Amneal is 1.14. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Amneal have, and what sector and industry does it belong to?

Amneal employs approximately 7,700 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Amneal's shares?

The free float of Amneal is 132.09M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $2.58B

5Y beta

 1.14

EPS (TTM)

 -$0.684

Free Float

 132.09M

Revenue (TTM)

 $2.68B

EBITDA (TTM)

 $545.27M

Free Cashflow (TTM)

 $229.23M

Pricing

1D span
$8.246$8.603
52W span
$4.16$9.475

Analyst Ratings

The price target is $8.25 and the stock is covered by 4 analysts.

Buy

4

Hold

0

Sell

0

Information

Amneal Pharmaceuticals, Inc., is a fully integrated global essential medicine company. The Company is engaged in the development, manufacturing, and distribution of a diverse portfolio of approximately 270 pharmaceutical products, primarily within the United States. The Company’s Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermal across a broad range of therapeutic categories. The Company's Specialty segment’s portfolio includes central nervous system disorders (Parkinson’s disease, spasticity, migraine), endocrinology (hypothyroidism), and other therapeutic areas. The Company’s AvKARE segment provides pharmaceuticals, medical and surgical products, and services to government, retail, and institutional markets.

7,700

Biotechnology & Drugs

Health Care

Identifier

ISIN

US03168L1052

Primary Ticker

AMRX

Knockouts

Join the conversation
Sign upLogin